The White House announced today it will nominate Dr. Stephen Hahn, an oncologist and chief medical executive at MD Anderson Cancer Center in Houston, as commissioner of the Food and Drug Administration (FDA).
Today the U.S. Senate will vote on a resolution under the Congressional Review Act that would stop Department of Health and Human Services (HHS) and Department of the Treasury guidance allowing individuals to use federal tax subsidies to purchase health insurance that does not meet coverage standards under the Affordable Care Act (ACA).
Washington, D.C. – Barriers to accessing appropriate therapies to address the physical and psychological side effects of cancer treatment continue to persist for patients and survivors, according to survey results from the American Cancer Society Cancer Action Network (ACS CAN).
Washington, D.C. – October 28, 2019 – Today the U.S. House of Representatives unanimously approved the Palliative Care and Hospice Education and Training Act (PCHETA).
WASHINGTON, DC – As organizations committed to protecting the health of our nation’s children, we strongly urge the Trump Administration to side with America’s kids over the tobacco industry by implementing its plan to clear the market of all flavored e-cigarettes – including mint and menthol fla
Washington, D.C. – Today the House Energy and Commerce Subcommittee on Health is holding a hearing on legislation that would prohibit the sale of nearly all flavored tobacco products, including mint and menthol products, and raise the minimum age of sale of tobacco products to 21.
House Speaker, Nancy Pelosi (D-Calif.), introduced legislation intended to bring down patient drug costs.
The Senate Labor, Health and Human Services and Education Subcommittee (LHHS) posted a draft FY 2020 spending bill today that includes a $3 billion funding increase for the National Institutes of Health (NIH), a $5 million increase for cancer registries and a $1 million increase for skin cancer programs, both of which operate at the Centers for Disease Control and Prevention.
the Trump administration announced its intention to finalize compliance policy through the Department of Health and Human Services (HHS) and Food and Drug Administration (FDA), that would prohibit most flavored e-cigarettes, including mint and menthol-flavored products, from being on the market.
New initiative launches on heels of 33 states investigating more than 450 cases of lung illnesses associated with vaping, many of which involve teens and young adults